Lentinan-laden microspheres reprogram the tumor microenvironment and improve anti-PD-L1 efficacy

A “3C” strategy based on the conventional drug lentinan (LNT), the convertible material polylactic acid with controlled release of LNT (LNT@Mic) was designed.